Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001597528 | SCV001832285 | likely pathogenic | not provided | 2019-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002592515 | SCV003246618 | pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2024-04-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.His298Argfs*21) in the EVC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EVC2 are known to be pathogenic (PMID: 17024374, 19810119, 19876929). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of Ellis-van Creveld syndrome (PMID: 34627339). ClinVar contains an entry for this variant (Variation ID: 1224461). For these reasons, this variant has been classified as Pathogenic. |